Related Experiment Video
Updated: Apr 25, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Plasma B-type natriuretic peptide is a useful tool for assessing coronary heart disease risk in a Japanese general
Takuya Hasegawa1, Masanori Asakura1, Kazuo Eguchi2
1Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Insights
Plasma B-type natriuretic peptide (BNP) levels indicate higher coronary heart disease (CHD) risk in community populations. Elevated BNP effectively identifies individuals with moderate to high CHD risk, even without existing heart or kidney issues.
Area of Science:
- Cardiology
- Biomarkers
- Preventive Medicine
Background:
- B-type natriuretic peptide (BNP) is linked to cardiovascular prognosis.
- Accumulated cardiovascular risk factors predict future disease.
- BNP's role as a comprehensive marker for risk factor accumulation is under-explored.
Purpose of the Study:
- To investigate if plasma BNP levels serve as a comprehensive marker for accumulated cardiovascular risk factors.
- To assess the association between BNP levels and coronary heart disease (CHD) risk in a community-dwelling population.
Main Methods:
- A study of 1530 community-dwelling Japanese subjects (mean age 62) without heart disease or renal dysfunction.
- Coronary heart disease (CHD) risk was estimated using the Framingham function, categorizing participants into low, moderate, and high-risk groups.
- Plasma BNP levels were measured and analyzed for their ability to detect moderate- and high-risk subjects.
Main Results:
- The prevalence of moderate- and high-risk CHD subjects increased with higher plasma BNP levels in both genders.
- Plasma BNP demonstrated modest ability to detect these risk groups (AUC 0.755 for men, 0.700 for women).
- Optimal BNP thresholds for identifying moderate- and high-risk individuals were 12.0 pg/mL and 22.0 pg/mL, respectively, with good sensitivity and specificity.
Conclusions:
- Elevated plasma BNP levels are associated with increased CHD risk in a population free from overt heart disease or renal dysfunction.
- BNP can serve as a valuable biomarker for identifying individuals with accumulated cardiovascular risk factors.
- These findings support the use of BNP testing in community health checkups for cardiovascular risk assessment.
Abstract:
B-type natriuretic peptide (BNP) has been reported to be associated with cardiovascular prognosis in a community-based population. In addition, accumulation of individual cardiovascular risk factors is important in predicting an individual's risk of future cardiovascular disease. However, there have been few reports showing that BNP is a comprehensive marker of the accumulation of cardiovascular risk factors. We studied 1530 community-dwelling subjects without obvious heart diseases or renal dysfunction (mean age 62 ± 15 years; 569 men and 961 women) who participated in an annual health checkup in a rural Japanese community. Coronary heart disease (CHD) risk was estimated, and patients were placed into the following three groups based on the Framingham function: low risk, moderate risk and high risk. The prevalence of moderate- and high-risk subjects for CHD rose in both genders with increasing plasma BNP levels. The area under the receiver operating characteristic curve showed a modest ability of plasma BNP levels to detect these subjects (0.755 and 0.700 for men and women, respectively). The optimal thresholds for the identification of subjects with moderate- and high-risk disease were BNP concentrations of 12.0 and 22.0 pg ml(-1), with sensitivities of 70% and 66% and specificities of 71% and 63% for men and women, respectively. In conclusion, subjects with high plasma BNP levels were at higher risk for CHD in a population without obvious heart disease or renal dysfunction.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Assessment of blood pressure in brachial artery(two-step method)

